Benevolent AI
(0 out of 5)0 Saved
BenevolentAI uses AI to accelerate biopharma drug discovery and provide life science intelligence.
Please wait while we load the page
BenevolentAI (Euronext Amsterdam: BAI) is a company that applies advanced AI to accelerate biopharma drug discovery. Their next-generation platform targets the complex decisions that drive R&D, providing life science intelligence. They build technology in the service of science, bringing together science and technology teams to push AI and machine learning to new limits. They leverage their knowledge graph and proprietary ontologies to support scientists and executives in leveraging cutting-edge AI with confidence and precision.
The website provides information about BenevolentAI's platform and its applications in drug discovery. Users can explore the company's philosophy, contact them for more information, and access resources like regulatory archives, terms and conditions, privacy policy, cookie declaration, accessibility information, and a sitemap.
BenevolentAI’s name suggests a helpful AI tool, so if you want something that aims to be beneficial and smart, it’s worth considering despite the lack of details.
Pricing information not available
No products available
